IPGL

IPGL is a private holding company established in 1986 and located in London, United Kingdom. As a family office, it manages a diverse portfolio of investments across various sectors. The company focuses on long-term value creation and employs a strategic approach to investment, leveraging its expertise to identify and nurture growth opportunities. IPGL is committed to maintaining a sustainable and responsible investment strategy while supporting the development of its portfolio companies. Through its operations, IPGL aims to contribute positively to the economy while ensuring the financial well-being of its stakeholders.

Christopher Clothier

Investment Director

Past deals in British Virgin Islands

Juvenescence

Series B in 2019
Juvenescence Limited is a British Virgin Islands-based holding company focused on investing in the fields of human aging and longevity. The company aims to develop a comprehensive ecosystem of assets that target aging, age-related diseases, and regenerative medicine. By leveraging advancements in scientific and medical research, Juvenescence seeks to create therapeutics that significantly extend both healthspan and lifespan. Their approach involves forming partnerships with leading scientists and research institutions, in-licensing compounds from academia and industry, and developing novel therapies based on a deep understanding of the biological mechanisms of aging. Juvenescence's initiatives also encompass therapeutic strategies aimed at promoting healthy aging, metabolic health, and brain health, with the ultimate goal of addressing the societal implications of an aging population.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.